Eflora is a cream that significantly slows down the growth of facial hair in women. Eflora is a generic replica of the famous Vaniqa, manufactured by Bristol Myers Squibb, but it costs much less because there is no need to invest in research and market promotion. Positive results were obtained in 60% of women who used eflornithine cream (the active ingredient in the preparations) for 24 weeks. The visible effect comes after 2 months from the beginning of the application of the cream.
General information about Eflora
Vaniqa Facial Hair Growth Retarding Cream was recently approved by the US Food and Drug Administration (FDA). The active ingredient of the drug is eflornithine hydrochloride. Creams based on eflornithine hydrochloride are the only creams currently approved by the FDA to inhibit hair growth.
Vaniqa is a co-development of the companies Bristol-Myers Squibb and "Gillette" and is the first topical drug for facial hair removal. The companies joined forces to create a new drug in 1996. Bristol-Myers Squibb has conducted clinical trials, has received FDA approval for its use, and will be marketing it with Gillette ". Eflornithine Hydrochloride Cream inhibits an enzyme that is essential for the growth of facial hair.
Bristol-Myers Squibb has shown significant efficacy in this drug in reducing the growth of facial hair. Positive results were obtained in 60% of women who used the cream for 24 weeks. The visible effect occurs within 2 months from the beginning of the application of the cream, so for the first time women, according to representatives of the companies, can continue to use their usual methods of hair removal.
So far, only the effect of the cream on the face has been tested, and it is not known whether Eflora and Vaniqa work on other parts of the body. The preparations will not rid you of excess vegetation, but will only slow down hair growth by acting on the appropriate enzymes. Don't expect lightning fast results: Eflora and Vaniqa act gradually, and you will be able to fully assess their effectiveness in the fight against excess hair only after a few months. And if you stop using the cream, put 2 times a day, soon the hair will begin to grow at the same rate as before.
At the moment, Vaniqa is a prescription in the United States and is not prescribed for everyone, but only for excessive facial hair. Many properties of the drug have not yet been studied, and the only recorded side effect is skin irritation.
According to companies, the new drug has a large number of potential consumers, because in the United States alone there are more than 41 million women who desperately need it.
In most cases, excess facial hair in women is due to hereditary factors, but in some cases it is caused by excess androgens or polycystic ovary syndrome.
Followed by Bristol-Myers Squibb other the company - Ranbaxy Laboratories Limited has also released its own cream based on eflornithine hydrochloride, which is a generic drug for Vaniqa. That is, it is exactly the same in its composition and properties, but produced under its own brand - Eflora. These creams to combat excess facial hair for women are exactly the same in composition, everything said in this article applies to both Vaniqa and Eflora, except of course the shape and appearance of the packages.
A little about the manufacturer Eflora:
Ranbaxy Laboratories Limited is a well-known international pharmaceutical company that actively participates in the healthcare system of many countries around the world. Since its inception about 40 years ago, Ranbaxy Laboratories Limited has rapidly achieved a leading position in India and achieved a notable presence in the international pharmaceutical market. The range of products includes finished dosage forms, substances, veterinary drugs, diagnostic tools. In 2000, Ranbaxy Laboratories Limited acquired the generic division of BAYER AG-BASICS in Germany, thereby strengthening its position in Western Europe. In accordance with the agreement, Ranbaxy Laboratories Limited has been transferred the rights to 20 products marketed under the brand name "BAYER BASICS".
In 2006, Ranbaxy Laboratories Limited acquired the Romanian company Terapia, thus gaining new opportunities to work in the European market. In addition, the company has taken over the company Allen S.p.A., a division of GlaxoSmithKline in Italy; Ethimed NV, the 10th largest seller in the Belgian generic market; MUNDOGEN, GlaxoSmithKline Generic in Spain; South African pharmaceutical company Be-Tabs Pharmaceuticals (Pty) Limited.
The high reputation of Ranbaxy Laboratories Limited in the international arena is also the result of strict adherence to generally accepted international standards of ethical promotion of drugs, which is expressed in the correct attitude to competing manufacturers, advertising campaigns, and interaction with the medical community.
Based on user reviews on one of the leading American pharmaceutical sites Drugs.com, eflornithine creams give very good results. You can periodically check out new reviews on this site and translate text into the language you need using online translators like Google-translator.
Videos on Vaniqa you can find on YouTube at the link: https://www.youtube.com/results?search_query=Vaniqa
Eflora packaging form
Tube of cream 15 g.
Indications for the use of eflornithine
Excessive facial hair in women.
1 gram of cream contains:
- Eflornithine hydrochloride monohydrate, which corresponds to anhydrous Eflornithine hydrochloride - 139 mg (13.9% by weight)
- Methylparaben IP (Indian Pharmacopoeia) - 0.09% by mass
- Propylparaben IP (Indian Pharmacopoeia) - 0.03% by mass
- Phenoxyethanol BP (British Pharmacopoeia) - 0.28% w / w
How to use eflornithine
Apply a thin layer of 13.9% Eflora cream (eflornithine hydrochloride) to the affected areas of the face and the adjacent areas under the chin. Rub completely into skin. It is not recommended to wash the treated areas for at least 4 hours after applying the cream. Apply the cream twice a day with a minimum interval of 8 hours or as directed by your healthcare professional. With the use of Eflora cream, the patient should continue to use the prescribed hair removal methods. Eflora cream should be applied no earlier than 5 minutes after hair removal. Cosmetics and sunscreens should only be applied to treated areas after the cream has dried.
Side effects of eflornithine use
When using the cream, minor side effects may occur, such as temporary redness, burning sensation, tingling sensation, rashes, etc.